BMS-908662
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-908662, covering 2013-06-12 to 2016-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]